IL6 and neoplasm: To test whether this JAK-STAT-mediated lipid-autophagy pathogenic axis is conserved, we employed a mouse IL-6 tumor model: C57BL/6 mice bearing Lewis lung carcinoma (LLC) tumors engineered either to secrete IL-6 (LLC+IL-6) or not (LLC).